4.5 Article

Intratumoral PDGFB gene predominantly expressed in endothelial cells is associated with angiogenesis and lymphangiogenesis, but not with metastasis in breast cancer

Journal

BREAST CANCER RESEARCH AND TREATMENT
Volume 195, Issue 1, Pages 17-31

Publisher

SPRINGER
DOI: 10.1007/s10549-022-06661-w

Keywords

Angiogenesis; BRCA; Breast cancer; Lymphangiogenesis; Neoadjuvant chemotherapy; PDGFB

Categories

Funding

  1. US National Institutes of Health (NIH) [R37CA248018, R01CA250412, R01CA251545, R01EB029596]
  2. US Department of Defense BCRP [W81XWH-19-1-0674, W81XWH-19-1-0111]
  3. National Center for Advancing Translational Sciences of the NIH [KL2TR001413, UL1TR001412]
  4. National Cancer Institute, cancer center support grant [P30CA016056]

Ask authors/readers for more resources

This study found that PDGFB gene expression is associated with angiogenesis and lymphangiogenesis in breast cancer patients, but not with cellular proliferation or metastasis.
Purpose Platelet-derived growth factor B (PDGFB) is known to play essential roles in angiogenesis and lymphangiogenesis during development, and tumor growth and vessel stabilization in experimental models. However, whether these findings could be translated to breast cancer patients remains unclear. We hypothesized that PDGFB gene expression is associated with angiogenesis, cell proliferation, and clinical outcomes in breast cancer patients. Methods A total of 7635 primary breast cancer patients with full transcriptome and clinical data available from 13 independent cohorts were analyzed using in silico approach. The median value was used to divide each cohort into high and low PDGFB expression groups. Results High PDGFB gene expression was associated with increased expression of angiogenesis-related genes, higher amount of vascular cell infiltrations, and with enrichment of angiogenesis gene set, lymphangiogenesis-related gene expressions, lymphangiogenesis-related cell infiltrations, and enrichmentof lymphangiogenesis gene set in GSE96058 and validated by TCGA cohorts; however, not with lymphatic metastasis. PDGFB expression was neither associated with cell proliferation as assessed by Ki67 expression nor with Nottingham histological grade, or response to neoadjuvant chemotherapy. We found that PDGFB was most extensively expressed by endothelial and perivascular-like cells in the tumor microenvironment, and minimally by cancer cells consistently in two single-cell sequence cohorts. High PDGFB expression enriched TGF beta, epithelial-mesenchymal transition, hypoxia, and cancer stem cell-associated pathways. However, no association with distant metastasis was observed. Disease-specific and disease-free survival were worse in the high PDGFB expression group consistently in TCGA and METABRIC cohorts. Conclusion PDGFB is predominantly expressed in endothelial cells and is associated with angiogenesis and lymphangiogenesis, but not with cellular proliferation or metastasis in breast cancer.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available